ТREATMENT OF SEVERE ACUTE PANCREATITIS
Abstract
Acute pancreatitis is an acute inflammatory process of the pancreas with variable involvement of other regional tissues or other organ systems. The severe form of the disease occurs in 10-20% of cases, and
usually requires prolonged hospitalization due to a frequent local and systemic complications. Additionally, considerable mortality despite diagnostic and therapeutic advances, makes this disease a serious health
problem nowadays. The aim of this study was to conduct a review of randomized controlled trials to determine differences in the efficiency between standard methods of treatment for severe acute pancreatitis and new treatment ways in terms of decreased mortality.
Search of the "Medline" database of original scientific papers and systematic review articles was made, using a combination of the following keywords: acute pancreatitis, treatment, mortality. In total 914 papers were found, published in the last 13 years; 14 of 64 randomized controlled clinical trials met the selection criteria and were eligible for inclusion. From a total of 16 papers, the conservative treatment was related to 11, which includes some of the new treatment methods, while the effects of new methods of treatment have been the subject of research in the four studies. Combined endoscopic and surgical treatment was applied in only one study. The largest sample of 290 patients was included in the study with platelet activation factor antagonist, while the smallest sample of 22 patients was used in the study that compared total parenteral with enteral nutrition.
Continuous regional arterial infusion of protease inhibitors in combination with antibiotics, intravenous supplementation of alanyl-glutamine dipeptide and the early, high-volume continuous veno-venous hemofiltration showed the best results in the treatment of patients with severe acute pancreatitis. Also, the use of low molecular weight heparin and enteral nutrition significantly reduced mortality.
References
Garg PK. Acute Pancreatitis-ECAB. New Delhi: Else-vier Health Sciences, 2010.
Forsmark CE. Pancreatitis and its complications. Totowa: Humana Press Inc., 2005.
Klingensmith ME. The Washington Manual of Surgery. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2008.
Balthazar EJ. Imaging of the Pancreas: Acute and Chro-nic Pancreatitis. Berlin-Heidelberg: Springer-Verlag, 2007.
Gloor B, Schmidtmann AB, Worni М, Ahmed Z, Uhl W, Büchler MW. Pancreatic sepsis: prevention and therapy. Best Practice & Research Clinical Gastroenterology 2002; 16: 379-90.
Hirota M, Takada T, Kitamura N, et al. Fundamental and intensive care of acute pancreatitis. J Hepatobiliary Pancreat Sci 2010; 17: 45-52.
Jiang HL, Xue WJ, Li DQ, et al. Influence of continuo-us veno-venous hemofiltration on the course of acute pancreatitis. World J Gastroenterol 2005; 11: 4815-21.
Déchelotte P, Hasselmann M, Cynober L, et al. L-alanyl-L-glutamine dipeptide–supplemented total pa-renteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: The French controlled, randomized,double-blind, multicenter study. Crit Care Med 2006; 34: 598-604.
Xue P, Deng LH, Xia Q, et al. Impact of alanyl-gluta-mine dipeptide on severe acute pancreatitis in early stage. World J Gastroenterol 2008; 14: 474–8.
Wu XM, Ji KQ, Wang HY, Fu Li G, Zang B, Min Chen W. Total Enteral Nutrition in Prevention of Pan-creatic Necrotic Infection in Severe Acute Pancreatitis. Pancreas 2010; 39: 248-51.
Doley RP, Yadav TD, Wig JD, et al. Enteral Nutrition in Severe Acute Pancreatitis. JOP. J Pancreas 2009; 10: 157-62.
Louie BE, Noseworthy T, Hailey D, Gramlich LM, Ja-cobs P, Warnock GL. 2004 MacLean–Mueller Prize Enteral or parenteral nutrition for severe pancreatitis: a randomized controlled trial and health technology asses-sment. Can J Surg 2005; 48: 298–306.
Ola´h A, Pardavi G, Bela´gyi T, Nagy A, Issekutz A, Mohamed GE. Early Nasojejunal Feeding in Acute Pancreatitis Is Associated With a Lower Complication Rate. Nutrition 2002; 18: 259–62.
Sheng LX, Fu Q, Qin LJ, et al. Low Molecular Weight Heparin in the Treatment of Severe Acute Pancreatitis: A Multiple Centre Prospective Clinical Study. Asian J Surg 2009; 32: 89-94.
Van Santvoort HC, Besselink MG, Bakker OJ, et al. A Step-up Approach or Open Necrosectomy for Necroti-zing Pancreatitis. N Engl J Med 2010; 362: 1491-502.
Besselink MG, Van Santvoort HC, Nieuwenhuijs VB, et al. Minimally invasive ‘step-upapproach’ versus maximal necrosectomy in patients with acute necrotising pancreatitis (PANTER trial): design and rationale of a randomised controlled multicenter trial. BMC Surgery 2006; 6: 6.
Yu W, Li W, Wang Z, Ye X, Li N, Li J. Early percuta-neous transhepatic gallbladder drainage compared with endoscopic retrograde cholangiopancreatography and papillotomy treatment for severe gallstone associated acute pancreatitis. Postgrad Med J 2007; 83: 187-91.
Piavscik M, Rydzewska G, Milewski J, et al.The Re-sults of Severe Acute Pancreatitis Treatment With Continuous Regional Arterial Infusion of Protease Inhi-bitor and Antibiotic. A Randomized Controlled Study. Pancreas 2010; 39: 863-7.
Johnson CD, Kingsnorth AN, Imrie CW, et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 2001; 48: 62-9.
Bansal D, Bhalla А, Bhasin DK, et al. Safety and Efficacy of Vitamin-based Antioxidant Therapy in Pa-tients with Severe Acute Pancreatitis: A Randomized Controlled Trial. Saudi J Gastroenterol. 2011; 17: 174–9.